Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on June 23, 2005
J Am Soc Nephrol 16: 2296-2305, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2005020129

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005020129v1
16/8/2296    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terada, Y.
Right arrow Articles by Sasaki, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terada, Y.
Right arrow Articles by Sasaki, S.

Cell Biology

Aldosterone Stimulates Proliferation of Mesangial Cells by Activating Mitogen-Activated Protein Kinase 1/2, Cyclin D1, and Cyclin A

Yoshio Terada, Takahiko Kobayashi, Hitoshi Kuwana, Hiroyuki Tanaka, Seiji Inoshita, Michio Kuwahara and Sei Sasaki

Department of Nephrology, Tokyo Medical and Dental University, Tokyo, Japan

Address correspondence to: Dr. Yoshio Terada, Department of Nephrology, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81-3-5803-5214; Fax: 81-3-5803-5215; E-mail: yterada.kid{at}tmd.ac.jp

Received for publication February 2, 2005. Accepted for publication May 10, 2005.

Recently, attention has been focused on the role of aldosterone in the pathophysiology of hypertension and cardiovascular disease. Several clinical and experimental data support the hypothesis that aldosterone contributes to the progression of renal injury. However, the molecular mechanisms of the effects of aldosterone in signal transduction and the cell-cycle progression of mesangial cells are not well known. For determining the signaling pathway of aldosterone in cultured mesangial cells, the effects of aldosterone on the mitogen-activated protein kinase 1/2 (MAPK1/2) pathway and the promoter activities of cyclin D1, cyclin A, and cyclin E were investigated. First, it was shown that the mineralocorticoid receptor (MR) was expressed in rat mesangial cells and glomeruli and that aldosterone stimulated the proliferation of mesangial cells via the MR and MAPK1/2 pathway. Next, it was demonstrated that aldosterone stimulated Ki-RasA, c-Raf kinase, MEK1/2, and MAPK1/2 in rat mesangial cells. Aldosterone induced cyclin D1 and cyclin A promoter activities and protein expressions, as well as the increments of CDK2 and CDK4 kinase activities. The presence of CYP11B2 and 11{beta}-HSD2 mRNA in rat mesangial cells also was shown. In conclusion, aldosterone seems to exert mainly MR-induced effects that stimulate c-Raf, MEK1/2, MAPK1/2, the activities of CDK2 and CDK4, and the cell-cycle progression in mesangial cells. MR antagonists may serve as a potential therapeutic approach to mesangial proliferative disease.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. T. Mathew, H. Patni, A. N. Chaudhary, W. Liang, A. Gupta, P. N. Chander, G. Ding, and P. C. Singhal
Aldosterone induces mesangial cell apoptosis both in vivo and in vitro
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F73 - F81.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. Terada, H. Kuwana, T. Kobayashi, T. Okado, N. Suzuki, T. Yoshimoto, Y. Hirata, and S. Sasaki
Aldosterone-Stimulated SGK1 Activity Mediates Profibrotic Signaling in the Mesangium
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 298 - 309.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Bokemeyer, D. Panek, M. Kitahara, J. M. Trzaskos, C. E. Muller, J. Hockemeyer, U. Kunter, P. Boor, J. Floege, H. J. Kramer, et al.
The map kinase ERK regulates renal activity of cyclin-dependent kinase 2 in experimental glomerulonephritis
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3431 - 3441.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Gauer, V. Segitz, and M. Goppelt-Struebe
Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor
Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3154 - 3159.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Shibata, M. Nagase, S. Yoshida, H. Kawachi, and T. Fujita
Podocyte as the Target for Aldosterone: Roles of Oxidative Stress and Sgk1
Hypertension, February 1, 2007; 49(2): 355 - 364.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. C. Rump
Secondary rise of albuminuria under AT1-receptor blockade--what is the potential role of aldosterone escape?
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 5 - 8.
[Full Text] [PDF]


Home page
CJASNHome page
M. P. Ponda and T. H. Hostetter
Aldosterone Antagonism in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 668 - 677.
[Full Text] [PDF]


Home page
EndocrinologyHome page
F. E. Brennan and P. J. Fuller
Mammalian K-ras2 Is a Corticosteroid-Induced Gene in Vivo
Endocrinology, June 1, 2006; 147(6): 2809 - 2816.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP